Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
26.54
-0.86 (-3.14%)
At close: May 1, 2024, 4:00 PM
26.88
+0.34 (1.28%)
After-hours: May 1, 2024, 7:52 PM EDT

Q32 Bio Revenue

In the year 2023, Q32 Bio had annual revenue of $1.16M, a decrease of -63.97%.

Revenue (ttm)
$1.16M
Revenue Growth
-63.97%
P/S Ratio
273.88
Revenue / Employee
$31,243
Employees
37
Market Cap
316.61M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.16M-2.05M-63.97%
Dec 31, 20223.21M-30.76M-90.56%
Dec 31, 202133.97M31.27M1,157.25%
Dec 31, 20202.70M1.04M62.18%
Dec 31, 20191.67M-3.66M-68.70%
Dec 31, 20185.32M--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.76B
Amarin Corporation 306.91M
Esperion Therapeutics 116.33M
Caribou Biosciences 34.48M
Precigen 6.23M
Ocugen 6.04M
Sera Prognostics 306.00K
Revenue Rankings